STI embodies a deeper comprehension and knowledge. It's not only about seeing more; it's about knowing more and being empowered with the ability to make informed decisions and tailor treatment strategies effectively.
The efficacy of STI is strikingly illustrated in the following images showcasing a cluster of three malignant tumors, indicated by a yellow arrow. Notably, the smallest tumor in the cluster (upper-right), spans approximately 2mm!
Non-contact, non-invasive, infrared-based breast thermography is highly effective in identifying high-risk cases of breast cancer, as abnormal images serve as excellent prognosticators. However, it is unreliable in predicting low-risk outcomes, as the few or subtle signs identified in borderline and equivocal images can indicate various benign conditions. This uncertainty in interpreting results can lead to false reassurance for patients classified as low-risk. Statistics indicate between ten to twenty-five percent of patients classified as low-risk have a malignant tumor.
STI was developed to investigate and understand the underlying causes of cancer in cases classified as low-risk. STI surpassed all expectations, demonstrating outstanding thermal sensitivity and spatial resolution by detecting nascent tumors as small as approximately 2mm! A screening of 1,675 patients using STI revealed that between 10% and 25% of low-risk outcomes were cancerous. This remarkable finding highlights STI's ability to accurately identify malignant tumors, achieving a Positive Predictive Value of 95%.
Breast cancer survival rates have seen significant improvements over time, yet the mortality rate and instances of metastatic breast cancer have largely remained constant. This stagnation is partly due to the limitations of current diagnostic methods to detect tumors at their early stages. In this context, STI represents a pivotal advancement as it can identify breast tumors at their nascent stages, substantially earlier than what is possible with existing screening techniques.
ThermEval is proud of its accolade from Healthcare Business Review as Top Radiology Solutions Provider. This recognition is a testament to our innovative approach in the imaging field, particularly our contribution of Spatial Thermal Imaging to medical imaging. We are also delighted to celebrate the achievement of our affiliate, Thermogram Assessment Services (TAS) which by employing STI, has been honored as Best International Breast Thermal Image Interpretation Clinic - USA by Global Health & Pharma Magazine.
In Summary, Spatial Thermal Imaging is an award-winning, groundbreaking development in breast cancer detection. Its ability to non-invasively detect early-stage malignancies, combined with its safety and affordability, presents a promising avenue for primary screening and potentially reducing breast cancer mortality and metastasis. STI technology uses easily obtainable, cost-effective equipment that is already used in thousands of practices. Its safety, affordability, and precision in identifying early-stage malignancies make STI a significant leap forward in breast cancer screening and detection.